116 related articles for article (PubMed ID: 31537183)
41. Stage III follicular lymphoma: long-term follow-up and patterns of failure.
Ha CS; Kong JS; McLaughlin P; Tucker SL; Fayad LE; Hess MA; Wilder RB; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):748-54. PubMed ID: 14529780
[TBL] [Abstract][Full Text] [Related]
42. Long-term outcome of treatment for Hodgkin's disease: the University Hospital Sofia experience.
Gocheva L; Koleva I
Klin Onkol; 2010; 23(1):34-42. PubMed ID: 20192072
[TBL] [Abstract][Full Text] [Related]
43. Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
Hodgson DC; Tsang RW; Pintilie M; Sun A; Wells W; Crump M; Gospodarowicz MK
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1374-81. PubMed ID: 14630276
[TBL] [Abstract][Full Text] [Related]
44. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
Wang C; Li W; Liu C; He H; Bai O
Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
[TBL] [Abstract][Full Text] [Related]
45. Hodgkin's disease and age.
Specht L; Nissen NI
Eur J Haematol; 1989 Aug; 43(2):127-35. PubMed ID: 2792320
[TBL] [Abstract][Full Text] [Related]
46. The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation.
Bierman PJ; Lynch JC; Bociek RG; Whalen VL; Kessinger A; Vose JM; Armitage JO
Ann Oncol; 2002 Sep; 13(9):1370-7. PubMed ID: 12196362
[TBL] [Abstract][Full Text] [Related]
47. [The risk-adaptive strategies of Hodgkin's lymphoma therapy].
Filatova LV; Alekseev SM; Zyuzgin IS; Zhabina AS; Motalkina MS; Zverkova AA; Ishmatova IV; Kotova NA; Chudinovskikh AA; Zvyaginsteva DA; Khadonov UB; Semiglazova TY
Vopr Onkol; 2016; 62(2):330-9. PubMed ID: 30462433
[TBL] [Abstract][Full Text] [Related]
48. Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Boehme V; Zeynalova S; Kloess M; Loeffler M; Kaiser U; Pfreundschuh M; Schmitz N
Ann Oncol; 2007 Jan; 18(1):149-157. PubMed ID: 17018708
[TBL] [Abstract][Full Text] [Related]
49. Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution.
Frata P; Buglione M; Grisanti S; Bonetti B; Vitali E; De Stefani A; Magri E; Peveri A; Marini G; Rossi G; Magrini SM
Tumori; 2005; 91(6):456-62. PubMed ID: 16457141
[TBL] [Abstract][Full Text] [Related]
50. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
Liao Z; Ha CS; Fuller LM; Hagemeister FB; Cabanillas F; Tucker SL; Hess MA; Cox JD
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1047-56. PubMed ID: 9719114
[TBL] [Abstract][Full Text] [Related]
51. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.
Koh YW; Kang HJ; Park C; Yoon DH; Kim S; Suh C; Go H; Kim JE; Kim CW; Huh J
Oncologist; 2012; 17(6):871-80. PubMed ID: 22588324
[TBL] [Abstract][Full Text] [Related]
52. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
Mitarnun W; Suwiwat S; Pradutkanchana J
Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
[TBL] [Abstract][Full Text] [Related]
53. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.
Vaccher E; Tirelli U; Spina M; Talamini R; Errante D; Simonelli C; Carbone A
J Clin Oncol; 1996 Aug; 14(8):2217-23. PubMed ID: 8708710
[TBL] [Abstract][Full Text] [Related]
54. [Clinical analysis of childhood and adolescent Hodgkin's lymphoma: a report of 88 cases].
Xing PY; Shi YK; He XH; Zhou LQ; Dong M; Yang JL; Liu P
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):692-7. PubMed ID: 23159084
[TBL] [Abstract][Full Text] [Related]
55. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
56. Frequency and Pattern of Bone Marrow Infiltration in Classical Hodgkin's Lymphoma: Experience from Southern Pakistan.
Sultan S; Irfan SM; Parveen S; Haider SA; Masood M
Asian Pac J Cancer Prev; 2016; 17(4):1857-9. PubMed ID: 27221865
[TBL] [Abstract][Full Text] [Related]
57. [Expressions and prognostic significance of PTEN and PD-1 protein in patients with classical Hodgkin's lymphoma].
Xia B; Wu DW; Wang TT; Guo SQ; Wang Y; Yang HL; Xu W; Tian C; Zhang LY; Sun BC; Sotomayor EM; Zhang YZ
Zhonghua Xue Ye Xue Za Zhi; 2018 Oct; 39(10):839-844. PubMed ID: 30373357
[No Abstract] [Full Text] [Related]
58. Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
Zanini M; Viviani S; Santoro A; Soncini F; Bonfante V; Devizzi L; Villani F; Castellani MR; Negretti E; Zucali R
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):813-9. PubMed ID: 7525516
[TBL] [Abstract][Full Text] [Related]
59. Head and neck extranodal lymphoma in a single institute: a 17-year retrospective analysis.
Chi HS; Lee KW; Chiang FY; Tai CF; Wang LF; Yang SF; Lin SF; Kuo WR
Kaohsiung J Med Sci; 2012 Aug; 28(8):435-41. PubMed ID: 22892165
[TBL] [Abstract][Full Text] [Related]
60. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder JP; Mazanet R; Ferrara J; Rimm IJ; Guinan E; Bierer B; Gilliland G; Churchill WH; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
Biol Blood Marrow Transplant; 1997 Jun; 3(2):98-106. PubMed ID: 9267670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
